š Education
Dr. Paul earned his Ph.D. in Molecular and Human Genetics from Jadavpur University, India (2016), after completing a Master’s in Genetics at the University of Calcutta (2008). He began his academic journey with a Bachelor’s in Physiology from Presidency College, University of Calcutta (2006). His educational foundation laid the groundwork for his research focus on epigenetics, immunology, and cancer biology.
š¼ Experience
Dr. Paul’s professional career spans prestigious institutions, including Washington University (2024āPresent), University of Texas MD Anderson Cancer Center (2020ā2024), and CSIR-Indian Institute of Chemical Biology (2009ā2016). His work focuses on immunotherapy, monoclonal antibody production, and the genetic regulation of cancer. He has been a postdoctoral fellow, research scientist, and project assistant, contributing to several groundbreaking research projects in molecular biology, toxicology, and immunology.
š Awards and Honors
Dr. Paul has received notable accolades, such as the prestigious NIH-funded research project on INO80 chromatin remodeling. He was also honored with research excellence awards, including one from GEU, DDN in 2015, and the Early Career Research Award from SERB (2017). Additionally, he received travel grants from DST (2012) and presented a best paper at TriboIndia-2023 Conference.
š¬ Research Focus
Dr. Paul’s research is primarily centered on understanding tumor progression through circulatory tumor cell profiling, tumor remission and relapse monitoring, and novel monoclonal antibody development for immunotherapy. His work includes studying the infection dynamics of herpes viruses, epigenetic mechanisms of cancer, and identifying biomarkers for early disease detection. He aims to enhance therapeutic strategies through innovative platforms and experimental models.